Market Access What rare disease commercialisation in Europe teaches us - a... Rare disease launches are the ultimate stress test for European commercialisation.
Sales & Marketing Sponsored Company Profile – POA Pharma In a landscape shaped by regulatory complexity, POA Pharma is demonstrating that smart, regionally tailored growth can outperform scale.
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Digital Sovereign AI as the backbone of LSHC GCC innovation: Priorit... In recent times, Global Capability Centres (GCCs) have become drivers of innovation for global Life Sciences and Healthcare (LSHC) companies.
Sales & Marketing Sponsored Solution Spotlight: Viseven’s eWizard With the right process and tools, localisation can become a well-oiled machine.
Sales & Marketing Sponsored How to harmonise global content strategies with local needs ... Any pharma business operating on a global scale would naturally strive to execute a uniformed content marketing strategy across all markets.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
